BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 22378044)

  • 1. β₁Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy.
    Eke I; Deuse Y; Hehlgans S; Gurtner K; Krause M; Baumann M; Shevchenko A; Sandfort V; Cordes N
    J Clin Invest; 2012 Apr; 122(4):1529-40. PubMed ID: 22378044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous β1 integrin-EGFR targeting and radiosensitization of human head and neck cancer.
    Eke I; Zscheppang K; Dickreuter E; Hickmann L; Mazzeo E; Unger K; Krause M; Cordes N
    J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25663685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced radiosensitivity of head and neck squamous cell carcinoma cells by β1 integrin inhibition.
    Eke I; Dickreuter E; Cordes N
    Radiother Oncol; 2012 Aug; 104(2):235-42. PubMed ID: 22748391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting FAK radiosensitizes 3-dimensional grown human HNSCC cells through reduced Akt1 and MEK1/2 signaling.
    Hehlgans S; Eke I; Cordes N
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e669-76. PubMed ID: 22483702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of β1 integrins impairs DNA repair for radiosensitization of head and neck cancer cells.
    Dickreuter E; Eke I; Krause M; Borgmann K; van Vugt MA; Cordes N
    Oncogene; 2016 Mar; 35(11):1353-62. PubMed ID: 26073085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head and neck cancer cell radiosensitization upon dual targeting of c-Abl and beta1-integrin.
    Koppenhagen P; Dickreuter E; Cordes N
    Radiother Oncol; 2017 Sep; 124(3):370-378. PubMed ID: 28578803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual targeting of EGFR and focal adhesion kinase in 3D grown HNSCC cell cultures.
    Eke I; Cordes N
    Radiother Oncol; 2011 Jun; 99(3):279-86. PubMed ID: 21704406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.
    Casar B; Rimann I; Kato H; Shattil SJ; Quigley JP; Deryugina EI
    Oncogene; 2014 Jan; 33(2):255-68. PubMed ID: 23208492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α integrin targeting for radiosensitization of three-dimensionally grown human head and neck squamous cell carcinoma cells.
    Steglich A; Vehlow A; Eke I; Cordes N
    Cancer Lett; 2015 Feb; 357(2):542-8. PubMed ID: 25497870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1.
    Cordes N; Frick S; Brunner TB; Pilarsky C; Grützmann R; Sipos B; Klöppel G; McKenna WG; Bernhard EJ
    Oncogene; 2007 Oct; 26(48):6851-62. PubMed ID: 17471232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro.
    Mohamed AA; Thomsen A; Follo M; Zamboglou C; Bronsert P; Mostafa H; Amen A; Mekawy M; Grosu AL; Brunner TB
    Strahlenther Onkol; 2021 Jan; 197(1):27-38. PubMed ID: 32705304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR and β1-integrin targeting differentially affect colorectal carcinoma cell radiosensitivity and invasion.
    Poschau M; Dickreuter E; Singh-Müller J; Zscheppang K; Eke I; Liersch T; Cordes N
    Radiother Oncol; 2015 Sep; 116(3):510-6. PubMed ID: 26096850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting irradiation-induced mitogen-activated protein kinase activation in vitro and in an ex vivo model for human head and neck cancer.
    Affolter A; Muller MF; Sommer K; Stenzinger A; Zaoui K; Lorenz K; Wolf T; Sharma S; Wolf J; Perner S; Weber KJ; Freier K; Plinkert PK; Hess J; Weichert W
    Head Neck; 2016 Apr; 38 Suppl 1():E2049-61. PubMed ID: 26918677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase 1.
    Goel HL; Sayeed A; Breen M; Zarif MJ; Garlick DS; Leav I; Davis RJ; Fitzgerald TJ; Morrione A; Hsieh CC; Liu Q; Dicker AP; Altieri DC; Languino LR
    J Cell Physiol; 2013 Jul; 228(7):1601-9. PubMed ID: 23359252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D cell cultures of human head and neck squamous cell carcinoma cells are radiosensitized by the focal adhesion kinase inhibitor TAE226.
    Hehlgans S; Lange I; Eke I; Cordes N
    Radiother Oncol; 2009 Sep; 92(3):371-8. PubMed ID: 19729215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib.
    Timpson P; Wilson AS; Lehrbach GM; Sutherland RL; Musgrove EA; Daly RJ
    Cancer Res; 2007 Oct; 67(19):9304-14. PubMed ID: 17909038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of cortactin in head and neck squamous cell carcinomas can be uncoupled from augmented EGF receptor expression.
    Fantozzi I; Grall D; Cagnol S; Stanchi F; Sudaka A; Brunstein MC; Bozec A; Fischel JL; Milano G; Van Obberghen-Schilling E
    Acta Oncol; 2008; 47(8):1502-12. PubMed ID: 18607838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metoclopramide enhances the effect of ionizing radiation on xenografted squamous cell carcinoma of the head and neck.
    Lybak S; Kjellén E; Wennerberg J; Pero R
    Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1419-24. PubMed ID: 2262366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.
    Gorski DH; Beckett MA; Jaskowiak NT; Calvin DP; Mauceri HJ; Salloum RM; Seetharam S; Koons A; Hari DM; Kufe DW; Weichselbaum RR
    Cancer Res; 1999 Jul; 59(14):3374-8. PubMed ID: 10416597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation.
    Harari PM; Huang SM
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):427-33. PubMed ID: 11173137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.